CDC-RFA-DP21-2104: Promoting Cancer Surveillance Workforce, Education, and Data Use
Closed
This grant is closed. A newer notice from the same program is forecast: Promoting Cancer Surveillance Workforce, Education, and Data Use (CDC-RFA-DP-27-0076). Status: Expected deadline March 8, 2027. It is in our archive of Centers for Disease Control - NCCDPHP notices from 2021.
Centers for Disease Control - NCCDPHP offered grants of up to $500,000 (at least $300,000) to any type of organization. It expected to make one award worth $2.5 million in total. Applications closed on March 30, 2021.
From the official notice on Grants.gov, last changed March 24, 2021. Checked November 7, 2026.
- Award ceiling$500,000
- Award floor$300,000
- Total funding$2.5 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| CDC-RFA-DP-27-0076 | September 28, 2026 | Expected deadline March 8, 2027 | Forecast |
Key dates
| Posted | January 18, 2021 |
|---|---|
| Deadline | March 30, 2021 |
| Archived by Grants.gov | April 29, 2021 |
Who can apply
This opportunity was open to any type of organization.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past Promoting the Cancer Surveillance Workforce, Education and Data Use awards averaged $1.2 million; this notice allows up to $500,000 per award.
- Most of the program's money (100% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The charge of the National Program of Cancer Registries (NPCR) is to enhance national cancer data and statistics in order to help public health professionals understand and address the nation's cancer burden. Cancer is a reportable disease in all NPCR-funded states. Cancer registrars ensure that timely, accurate, and complete data are maintained on all types of cancer diagnosed and /or treated within a health care institution or within a defined population. Consequently, registrars at medical facilities (including hospitals, physicians’ offices, therapeutic radiation facilities, freestanding surgical centers, and pathology laboratories) and registrars employed by the central registries are actively involved in reporting accurate, timely and complete data. These data are then submitted annually to CDC by each NPCR funded central cancer registry, resulting in national cancer data that is dependent upon the cancer registrar workforce. A well trained, highly qualified workforce is critical to the success of NPCR and the value of all cancer data. The registry profession is small compared to other allied health professions (Health Information Management 40,000 versus Certified Tumor Registrars at 5,657). Lack of knowledge about the profession and available educational opportunities contribute to the small number of certified registrars. A limited job market results in a profession that must be promoted to recruit new cancer registrars and retain current ones. The 2013 NCRA/NPCR Workload and Time Management Study: Guidelines for Central Cancer Registry Programs supports earlier studies stating that the factor most frequently cited by informants as influencing the supply of cancer registrars was the lack of visibility of the profession. This NOFO will build upon the success of the National Program of Cancer Registries (NPCR) by expanding opportunities to enhance registrars’ capacity, resources to support recruitment and retention and promote cancer surveillance data. Moreover, the iteration of this project will build upon the DP16-1605and the successes and lessons learned from that project.
Who has won Promoting the Cancer Surveillance Workforce, Education and Data Use grants before
From fiscal 2021 to 2025, Promoting the Cancer Surveillance Workforce, Education and Data Use (93.832) awarded $1.2 million across 1 grant award, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| National Cancer Registrars Association | Virginia | 1 | $1.2 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-DP-27-0076, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-DP21-2104 still open?
No. It closed on March 30, 2021. A newer notice is forecast: CDC-RFA-DP-27-0076, expected deadline March 8, 2027.
Who can apply for Promoting Cancer Surveillance Workforce, Education, and Data Use?
Centers for Disease Control - NCCDPHP accepted applications from any type of organization.
What is the deadline for Promoting Cancer Surveillance Workforce, Education, and Data Use?
Closed March 30, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $2.5 million in total for one award.
Who has won Promoting the Cancer Surveillance Workforce, Education and Data Use grants before?
The largest recipients over five fiscal years were National Cancer Registrars Association. The program made 1 awards worth $1.2 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)